The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-ethyl-4-(4-(3-methoxypyridin-2-yl)piperidin-1-yl)azepane-1-carboxamide ID: ALA4474926
PubChem CID: 155537519
Max Phase: Preclinical
Molecular Formula: C20H32N4O2
Molecular Weight: 360.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCNC(=O)N1CCCC(N2CCC(c3ncccc3OC)CC2)CC1
Standard InChI: InChI=1S/C20H32N4O2/c1-3-21-20(25)24-12-5-6-17(10-15-24)23-13-8-16(9-14-23)19-18(26-2)7-4-11-22-19/h4,7,11,16-17H,3,5-6,8-10,12-15H2,1-2H3,(H,21,25)
Standard InChI Key: KZOVGRHHJQWGNJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.2426 -5.0697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0580 -5.0708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4649 -4.3663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0575 -3.6602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2390 -3.6630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8358 -4.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2832 -4.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6904 -5.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5040 -5.0725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9166 -4.3667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5094 -3.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6896 -3.6533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4650 -2.9519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2822 -2.9506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7338 -4.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0940 -3.6405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8929 -3.4597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0906 -5.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5318 -3.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8883 -5.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5275 -4.7833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2630 -5.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3223 -5.9545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9391 -4.6805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0578 -6.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1171 -7.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
3 7 1 0
4 13 1 0
13 14 1 0
10 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
17 19 1 0
18 20 1 0
19 21 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.50Molecular Weight (Monoisotopic): 360.2525AlogP: 2.85#Rotatable Bonds: 4Polar Surface Area: 57.70Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.14CX LogP: 1.23CX LogD: -0.51Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.90Np Likeness Score: -1.34
References 1. Yang Q, Lachapelle EA, Kablaoui NM, Webb D, Popiolek M, Grimwood S, Kozak R, O'Connor RE, Lazzaro JT, Butler CR, Zhang L.. (2019) Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres., 10 (6): [PMID:31223452 ] [10.1021/acsmedchemlett.9b00106 ]